Medibank Private Limited (MDBPF)

Inozyme Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	9,060	6,854	6,452	6,167	6,525	5,685
Market Cap Growth	-3.35%	6.23%	4.62%	-5.49%	14.77%	-15.64%
Enterprise Value	8,900	6,530	6,223	5,814	6,144	5,468
PE Ratio	29.90	20.86	31.41	22.72	19.73	26.14
PS Ratio	1.76	1.28	1.31	1.26	1.24	1.22
PB Ratio	6.14	4.46	4.32	4.60	4.57	4.58
P/FCF Ratio	23.74	11.92	54.86	9.51	18.47	14.47
P/OCF Ratio	23.26	11.83	52.54	9.44	18.05	14.39
EV/Sales Ratio	1.64	1.22	1.26	1.19	1.17	1.17
EV/EBITDA Ratio	17.54	13.26	20.59	14.77	12.53	16.65
EV/EBIT Ratio	18.95	13.52	21.20	15.13	12.88	17.46
EV/FCF Ratio	23.32	11.36	52.92	8.96	17.39	13.92
Debt / Equity Ratio	0.09	0.10	0.03	0.04	0.05	0.06
Debt / EBITDA Ratio	0.27	0.28	0.11	0.13	0.14	0.22
Debt / FCF Ratio	0.34	0.25	0.31	0.08	0.20	0.19
Quick Ratio	2.30	1.88	2.15	1.50	1.72	1.73
Current Ratio	2.32	1.89	2.17	1.52	1.74	1.76
Asset Turnover	2.06	1.84	1.72	1.68	1.83	1.84
Return on Equity (ROE)	21.00%	21.83%	14.73%	20.45%	23.82%	16.91%
Return on Assets (ROA)	11.26%	10.38%	6.42%	8.23%	10.37%	7.68%
Return on Capital (ROIC)	18.42%	18.77%	12.76%	17.34%	20.35%	14.64%
Earnings Yield	3.34%	4.79%	3.18%	4.40%	5.07%	3.82%
Earnings Yield	3.34%	4.79%	3.18%	4.40%	5.07%	3.82%
FCF Yield	4.21%	8.39%	1.82%	10.52%	5.42%	6.91%
Dividend Yield	-	5.57%	4.74%	4.40%	5.01%	4.36%
Payout Ratio	93.38%	86.68%	121.35%	90.89%	75.52%	114.51%
Total Shareholder Return	-	5.57%	4.74%	4.40%	5.01%	4.36%

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.